BR112016020987A8 - método de identificação de receptores de aloenxerto renal, kit, conjunto de assinatura gênica, método de seleção de paciente e uso de um agente imunossupressivo - Google Patents
método de identificação de receptores de aloenxerto renal, kit, conjunto de assinatura gênica, método de seleção de paciente e uso de um agente imunossupressivoInfo
- Publication number
- BR112016020987A8 BR112016020987A8 BR112016020987A BR112016020987A BR112016020987A8 BR 112016020987 A8 BR112016020987 A8 BR 112016020987A8 BR 112016020987 A BR112016020987 A BR 112016020987A BR 112016020987 A BR112016020987 A BR 112016020987A BR 112016020987 A8 BR112016020987 A8 BR 112016020987A8
- Authority
- BR
- Brazil
- Prior art keywords
- signature set
- kit
- immunosuppressive agent
- renal allograft
- patient selection
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000004547 gene signature Effects 0.000 title abstract 2
- 229940125721 immunosuppressive agent Drugs 0.000 title abstract 2
- 239000003018 immunosuppressive agent Substances 0.000 title abstract 2
- 238000010187 selection method Methods 0.000 title 1
- 230000001684 chronic effect Effects 0.000 abstract 2
- 230000002068 genetic effect Effects 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
método de identificação de receptores de aloenxerto renal, kit, conjunto de assinatura gênica, método de seleção de paciente e uso de um agente imunossupressivo. método de identificação de receptores de aloenxerto renal em risco de lesões de aloenxertos crônicos ou fibrose intersticial e atrofia tubular (if/ta), por meio de comparação do nível de transcrição de um conjunto de assinatura genética previamente selecionado com o nível de transcrição de um padrão de comparação e diagnóstico do receptor como estando em risco de lesão de aloenxerto crônica caso o nível de transcrição do conjunto de assinatura genética previamente selecionado seja significativamente mais alto que o nível de transcrição do padrão de comparação.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461951651P | 2014-03-12 | 2014-03-12 | |
| US61/951,651 | 2014-03-12 | ||
| PCT/US2015/020291 WO2015138803A1 (en) | 2014-03-12 | 2015-03-12 | Method for identifying kidney allograft recipients at risk for chronic injury |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112016020987A2 BR112016020987A2 (pt) | 2017-08-15 |
| BR112016020987A8 true BR112016020987A8 (pt) | 2021-07-06 |
| BR112016020987B1 BR112016020987B1 (pt) | 2023-11-14 |
Family
ID=54072426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016020987-7A BR112016020987B1 (pt) | 2014-03-12 | 2015-03-12 | Método de identificação de receptores de aloenxerto renal e método de seleção de receptor do aloenxerto renal |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10941446B2 (pt) |
| EP (1) | EP3117220B1 (pt) |
| CN (2) | CN106461679B (pt) |
| AU (1) | AU2015229270B2 (pt) |
| BR (1) | BR112016020987B1 (pt) |
| CA (1) | CA2942384C (pt) |
| ES (1) | ES2824108T3 (pt) |
| WO (1) | WO2015138803A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015138803A1 (en) * | 2014-03-12 | 2015-09-17 | Icahn School Of Medicine At Mount Sinai | Method for identifying kidney allograft recipients at risk for chronic injury |
| US11572587B2 (en) | 2014-06-26 | 2023-02-07 | Icahn School Of Medicine At Mount Sinai | Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets |
| WO2017070441A1 (en) * | 2015-10-23 | 2017-04-27 | Icahn School Of Medicine At Mount Sinai | Identifying and treating cancer patients who are suitable for a targeted therapy using an hdac6 inhibitor |
| WO2017100259A1 (en) * | 2015-12-08 | 2017-06-15 | Icahn School Of Medicine At Mount Sinai | Pretransplant prediction of post-transplant acute rejection |
| CA3058406A1 (en) * | 2017-03-30 | 2018-10-04 | The Board Of Trustees Of The University Of Illinois | Method and kit for diagnosing early stage pancreatic cancer |
| WO2019122303A1 (en) | 2017-12-22 | 2019-06-27 | Vib Vzw | Predicting chronic allograft injury through ischemia-induced dna methylation |
| CN112236137A (zh) | 2018-04-16 | 2021-01-15 | 西奈山伊坎医学院 | 利用移植前接受者血液中转录组标志预测急性排斥反应和肾脏同种异体移植物丧失的方法和试剂盒 |
| EP3983562A1 (en) | 2019-06-17 | 2022-04-20 | Vib Vzw | Predicting chronic allograft injury through age-related dna methylation |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| WO1996039154A1 (en) | 1995-06-06 | 1996-12-12 | Isis Pharmaceuticals, Inc. | Oligonucleotides having phosphorothioate linkages of high chiral purity |
| US5985662A (en) | 1995-07-13 | 1999-11-16 | Isis Pharmaceuticals Inc. | Antisense inhibition of hepatitis B virus replication |
| US20030104371A1 (en) * | 1997-09-24 | 2003-06-05 | Strom Terry B. | Methods of evaluating transplant rejection |
| JP4212278B2 (ja) | 2001-03-01 | 2009-01-21 | 日本たばこ産業株式会社 | 移植片拒絶反応抑制剤 |
| US7955800B2 (en) | 2002-06-25 | 2011-06-07 | Advpharma Inc. | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients |
| WO2004074815A2 (en) * | 2003-02-14 | 2004-09-02 | Beth Israel Deaconess Medical Center, Inc. | Predicting graft rejection |
| HN2004000285A (es) | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
| WO2005042725A2 (en) | 2003-11-03 | 2005-05-12 | Genenews, Inc. | Liver cancer biomarkers |
| WO2008073922A2 (en) | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Functions and targets of let-7 micro rnas |
| CN1846699A (zh) * | 2005-04-13 | 2006-10-18 | 中南大学湘雅医院 | 1－(取代苯基)－5－甲基－2－(1h) 吡啶酮(i)化合物用于制备抗除肾间质纤维化外其他器官纤维化或组织纤维化药物的应用 |
| ES2600460T3 (es) | 2005-05-10 | 2017-02-09 | Intermune, Inc. | Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés |
| EP1731620A1 (en) | 2005-06-07 | 2006-12-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for the diagnosis of immune graft tolerance |
| EP1934369A2 (en) | 2005-09-29 | 2008-06-25 | Epigenomics AG | Methods and nucleic acids for the analysis of gene expression associated with tissue classification |
| GB0524110D0 (en) | 2005-11-28 | 2006-01-04 | Univ Cambridge Tech | Biomarkers and methods for identification of agents useful in the treatment of affective disorders |
| GB0605217D0 (en) | 2006-03-15 | 2006-04-26 | Novartis Ag | Method and compositions for assessing acute rejection |
| MX2008014110A (es) | 2006-05-02 | 2008-11-14 | Therakos Inc | Metodos y reactivos para detectar la susceptibilidad a la enfermedad del injerto versus el hospedero o mortalidad relacionada con el transplante. |
| US20070269827A1 (en) * | 2006-05-18 | 2007-11-22 | Oklahoma Medical Research Foundation | Predicting and Diagnosing Patients With Autoimmune Disease |
| US20080274911A1 (en) | 2006-11-07 | 2008-11-06 | Burington Bart E | Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof |
| ES2814027T3 (es) | 2006-12-27 | 2021-03-25 | Abion Inc | Procedimiento de procesamiento y análisis de datos de expresión génica para identificar genes de referencia endógenos |
| EP4219762A1 (en) | 2008-02-01 | 2023-08-02 | The General Hospital Corporation | Use of microvesicles in diagnosis and prognosis of medical diseases and conditions |
| US20110189680A1 (en) | 2008-05-30 | 2011-08-04 | The University Of British Columbia | Methods of Diagnosing Rejection of a Kidney Allograft Using Genomic or Proteomic Expression Profiling |
| WO2010009735A2 (en) | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Combinatorial analysis and repair |
| EP2387618B1 (en) | 2009-01-15 | 2014-05-21 | The Board of Trustees of The Leland Stanford Junior University | Biomarker panel for diagnosis and prediction of graft rejection |
| DK2389582T3 (en) | 2009-01-20 | 2016-07-18 | Cambridge Entpr Ltd | Methods for prognosis of the risk of autoimmune diseases |
| CN102666581A (zh) | 2009-08-31 | 2012-09-12 | 艾普利穆恩公司 | 用于抑制移植物排斥的方法和组合物 |
| IN2012DN02485A (pt) | 2009-09-03 | 2015-08-28 | Hoffmann La Roche | |
| US20130064835A1 (en) * | 2009-10-08 | 2013-03-14 | Ann Marie Schmidt | Rage regulates rock activity in cardiovascular disease |
| PT2496720T (pt) * | 2009-11-06 | 2020-10-12 | Univ Leland Stanford Junior | Diagnóstico não-invasivo de rejeição de enxertos em pacientes sujeitos a transplantes de órgãos |
| CN102762743A (zh) | 2009-12-09 | 2012-10-31 | 阿维埃尔公司 | 用于心血管疾病的诊断和分类的生物标记物检验 |
| US9535075B2 (en) * | 2010-03-25 | 2017-01-03 | The Board Of Trustees Of The Leland Stanford Junior University | Protein and gene biomarkers for rejection of organ transplants |
| AU2011237669B2 (en) | 2010-04-06 | 2016-09-08 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for disease |
| JP5974215B2 (ja) | 2010-05-12 | 2016-08-24 | リージェンメド（ケイマン）エルティーディー． | 生理活性腎臓細胞 |
| US20140045915A1 (en) | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| US20120107825A1 (en) | 2010-11-01 | 2012-05-03 | Winger Edward E | Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna |
| WO2012115885A1 (en) | 2011-02-22 | 2012-08-30 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers |
| CN103797131A (zh) | 2011-06-16 | 2014-05-14 | 卡里斯生命科学卢森堡控股有限责任公司 | 生物标志物组合物和方法 |
| CA2848516C (en) * | 2011-09-22 | 2021-06-15 | Maria U. Hutchins | Detection of isotype profiles as signatures for disease |
| US20130142728A1 (en) | 2011-10-27 | 2013-06-06 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
| FI123683B (en) | 2011-11-28 | 2013-09-13 | Teknologian Tutkimuskeskus Vtt | Process for catalytic oxidation of a natural composition comprising unsaturated fatty acids and / or esters thereof and use of a mixture obtained therefrom to produce mono-, oligo- and / or polyesters |
| EP2785839A2 (en) | 2011-11-30 | 2014-10-08 | University of Bremen | Expression of mirnas in placental tissue |
| KR20140114415A (ko) * | 2012-01-13 | 2014-09-26 | 제넨테크, 인크. | Vegf 길항제로의 치료를 위한 환자를 확인하기 위한 생물학적 마커 |
| EP2899688A4 (en) | 2012-09-20 | 2016-04-27 | Sharp Kk | IMAGE PROCESSING DEVICE, IMAGE DISPLAY DEVICE, IMAGE DEVICE, IMAGE PRINTING DEVICE, GRAD CONVERTING PROCESS AND PROGRAM |
| WO2014055117A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
| WO2014071205A1 (en) | 2012-11-02 | 2014-05-08 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies |
| US20140329704A1 (en) | 2013-03-28 | 2014-11-06 | President And Fellows Of Harvard College | Markers for mature beta-cells and methods of using the same |
| CN103421905A (zh) | 2013-08-20 | 2013-12-04 | 张飚 | 从血液中检测用于诊断脑卒中的microRNA的方法 |
| CA2923700A1 (en) | 2013-09-09 | 2015-03-12 | The Scripps Research Institute | Methods and systems for analysis of organ transplantation |
| WO2015138803A1 (en) * | 2014-03-12 | 2015-09-17 | Icahn School Of Medicine At Mount Sinai | Method for identifying kidney allograft recipients at risk for chronic injury |
| WO2015200873A1 (en) | 2014-06-26 | 2015-12-30 | Icahn School Of Medicine At Mount Sinai | Methods for diagnosing risk of renal allograft fibrosis and rejection |
| US11572587B2 (en) | 2014-06-26 | 2023-02-07 | Icahn School Of Medicine At Mount Sinai | Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets |
| WO2017100259A1 (en) | 2015-12-08 | 2017-06-15 | Icahn School Of Medicine At Mount Sinai | Pretransplant prediction of post-transplant acute rejection |
| EP3420102B1 (en) | 2016-02-22 | 2024-04-03 | Massachusetts Institute of Technology | Methods for identifying and modulating immune phenotypes |
| US20190194760A1 (en) | 2016-05-25 | 2019-06-27 | Curevac Ag | Novel biomarkers |
| US20180356402A1 (en) | 2017-06-08 | 2018-12-13 | The Cleveland Clinic Foundation | Urine biomarkers for detecting graft rejection |
| CN112236137A (zh) | 2018-04-16 | 2021-01-15 | 西奈山伊坎医学院 | 利用移植前接受者血液中转录组标志预测急性排斥反应和肾脏同种异体移植物丧失的方法和试剂盒 |
-
2015
- 2015-03-12 WO PCT/US2015/020291 patent/WO2015138803A1/en active Application Filing
- 2015-03-12 CN CN201580024911.0A patent/CN106461679B/zh active Active
- 2015-03-12 BR BR112016020987-7A patent/BR112016020987B1/pt active IP Right Grant
- 2015-03-12 CN CN201811063221.8A patent/CN109207580B/zh active Active
- 2015-03-12 US US15/125,009 patent/US10941446B2/en active Active
- 2015-03-12 CA CA2942384A patent/CA2942384C/en active Active
- 2015-03-12 EP EP15761612.9A patent/EP3117220B1/en active Active
- 2015-03-12 ES ES15761612T patent/ES2824108T3/es active Active
- 2015-03-12 AU AU2015229270A patent/AU2015229270B2/en active Active
-
2021
- 2021-02-01 US US17/164,607 patent/US11674181B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN106461679A (zh) | 2017-02-22 |
| EP3117220A4 (en) | 2017-08-30 |
| EP3117220A1 (en) | 2017-01-18 |
| ES2824108T3 (es) | 2021-05-11 |
| US20210230700A1 (en) | 2021-07-29 |
| AU2015229270A1 (en) | 2016-10-20 |
| CN109207580B (zh) | 2022-03-11 |
| AU2015229270B2 (en) | 2020-12-24 |
| US10941446B2 (en) | 2021-03-09 |
| WO2015138803A1 (en) | 2015-09-17 |
| CN109207580A (zh) | 2019-01-15 |
| CA2942384A1 (en) | 2015-09-17 |
| US11674181B2 (en) | 2023-06-13 |
| BR112016020987A2 (pt) | 2017-08-15 |
| US20170114407A1 (en) | 2017-04-27 |
| CA2942384C (en) | 2024-01-23 |
| BR112016020987B1 (pt) | 2023-11-14 |
| EP3117220B1 (en) | 2020-07-08 |
| CN106461679B (zh) | 2018-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016020987A8 (pt) | método de identificação de receptores de aloenxerto renal, kit, conjunto de assinatura gênica, método de seleção de paciente e uso de um agente imunossupressivo | |
| WO2018132635A8 (en) | Methods for analyzing t cell receptors and b cell receptors | |
| EP3140767B8 (en) | Method, apparatus, and system for managing user accounts in the event of conflicting login names | |
| MX2017007535A (es) | Sistema y metodos para derivar biomarcadores de firmas geneticas de la respuesta a antagonistas de muerte programada 1 (pd-1). | |
| AU2016204020B2 (en) | Systems and methods for identifying and suggesting emoticons | |
| IL247370A0 (en) | A method for diagnosing colon cancer from a human stool sample using quantitative PCR, primers and a kit | |
| SA518390949B1 (ar) | طريقة لتحديد المسامية المرتبطة بمادة عضوية في بئر أو تكوين | |
| EP3347695A4 (en) | ANALYZE INSTRUMENT, APPROPRIATE SYSTEMS AND METHOD | |
| EP3142555A4 (en) | Apparatus, system and method for measuring urine flow and/or quantity | |
| EP3094072A3 (en) | Information processing system, information processing apparatus, and program | |
| EP3432399A4 (en) | FUEL CELL SYSTEM AND ITS CONTROL DEVICE, AND METHOD FOR CONTROLLING FUEL CELL SYSTEM | |
| MX2016013991A (es) | Metodo y sistema para determinacion de humectabilidad resuelta espacialmente. | |
| EP3452147A4 (en) | DEVICES, METHODS AND SYSTEMS FOR THE ADMINISTRATION OF MEDICINES WITH MEDICINE KITS | |
| EP3710918A4 (en) | DEVICE AND METHOD FOR DETECTING, QUANTIFYING AND PROVIDING FEEDBACK TO USER GESTURES | |
| EP3232778A4 (en) | Systems, apparatus, and methods for analyzing blood cell dynamics | |
| EP2773061A3 (en) | A method and an apparatus for deriving secret information from a series of response values and a method and an apparatus for providing helper data allowing to derive a secret information | |
| EP3506406A4 (en) | FUEL CELL SYSTEM, CONTROL METHOD FOR FUEL CELL SYSTEM, AND COMPUTER PROGRAM | |
| EP3525188A4 (en) | TOILET SYSTEM AND TOILET MANAGEMENT METHOD AND PROGRAM | |
| EP4202441A3 (en) | Gene expression profile in macrophages for the diagnosis of cancer | |
| EP3531280A4 (en) | METHOD, SYSTEM AND APPARATUS FOR ACCELERATOR LOADING | |
| EP3506407A4 (en) | FUEL CELL SYSTEM, CONTROL METHOD FOR FUEL CELL SYSTEM, AND COMPUTER PROGRAM | |
| EP3404445A4 (en) | Gnss correction data distribution device, gnss correction data distribution system, and gnss correction data distribution method | |
| NZ751481A (en) | Metabolite biomarkers for diseases associated with the contact activation system | |
| WO2014145467A3 (en) | Multiplexed digital assay for variant and normal forms of a gene of interest | |
| BR112017001764A2 (pt) | método, e, aparelho |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/03/2015, OBSERVADAS AS CONDICOES LEGAIS |